Cite
HARVARD Citation
Satilmis, H. et al. (2023). Targeting the β2‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism. Journal of pathology. 259 (1), pp. 69-80. [Online].